Paul J. Shami, MD
Professor of Medicine
Specialities: Myelodysplastic Syndromes, Myelodysplastic Syndromes, Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia
Spoken languages: English

Specialities: Myelodysplastic Syndromes, Myelodysplastic Syndromes, Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia
Spoken languages: English
Dr. Paul Shami is a Professor of Medicine in the Division of Hematology and Hematologic Malignancies at the University of Utah and is a Member and Clinical Investigator at the University’s Huntsman Cancer Institute (HCI). Dr. Shami also holds an Adjunct appointment as a Professor of Molecular Pharmaceutics at the University of Utah. He is Board Certified in Hematology and Medical Oncology. He started at the University of Utah in 1997. Dr. Shami oversees leukemia clinical trials at Huntsman Cancer Institute. His research also includes different strategies in drug discovery and drug development. Because of his expertise in the treatment of blood cancers, he serves or has served on the Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia and Myelodysplastic Syndrome panels of the National Cancer Center Network (NCCN).
Huntsman Cancer Institute at the University of Utah: 2000 Cir of Hope Dr #1950, Salt Lake City, UT 84112, USA
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.